John J Scarcelli
5PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 22, 2022
A genetic off-target event in a site-specific integration cell line expressing monoclonal antibody has no impact on commercial suitability.Barbara Tevelev, Andre Chambers, Swap Ghosh
|Apr 23, 2021
Genetic rearrangement during site specific integration event facilitates cell line development of a bispecific molecule.Barbara Tevelev, Himakshi Patel, Kathleen Shields
|Oct 10, 2018
Transient CHO expression platform for robust antibody production and its enhanced N-glycan sialylation on therapeutic glycoproteins.Xiaotian Zhong, Weijun Ma, Caryl L Meade
|Apr 26, 2018
Analytical subcloning of a clonal cell line demonstrates cellular heterogeneity that does not impact process consistency or robustness.John J Scarcelli, Megan Hone, Kathryn Beal
|May 09, 2017
Strategic deployment of CHO expression platforms to deliver Pfizer's Monoclonal Antibody Portfolio.John J Scarcelli, Tanya Q Shang, Tim Iskra
Pageof 1
